CDK Inhibitor p18INK4c Is a Downstream Target of GATA3 and Restrains Mammary Luminal Progenitor Cell Proliferation and Tumorigenesis

Cancer Cell

Volumn 15, Issue 5, 2009, Pages 389-401

  Pei, Xin Hai ^a   Bai, Feng ^a   Smith, Matthew D ^a   Usary, Jerry ^a   Fan, Cheng ^a   Pai, Sung Yun ^c   Ho, I Cheng ^c   Perou, Charles M ^a,b   Xiong, Yue ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

CELLCYCLE; STEMCELL

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; TRANSCRIPTION FACTOR GATA 3;

ANIMAL CELL; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CARCINOGENESIS; CELL EXPANSION; CELL POPULATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DOWN REGULATION; ENDOPLASMIC RETICULUM; FEMALE; GENE DELETION; HUMAN; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PENETRANCE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN TARGETING; PUBERTY; STEM CELL; TRANSCRIPTION REGULATION;

MUS;

EID: 65449123852     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2009.03.004     Document Type: Article

References (48)

1. Althuis M.D., Fergenbaum J.H., Garcia-Closas M., Brinton L.A., Madigan M.P., and Sherman M.E. Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol. Biomarkers Prev. 13 (2004) 1558-1568
2. Asselin-Labat M.L., Sutherland K.D., Barker H., Thomas R., Shackleton M., Forrest N.C., Hartley L., Robb L., Grosveld F.G., van der Wees J., et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat. Cell Biol. 9 (2007) 201-209
3. INK4c sensitizes mice to carcinogen-induced tumorigenesis. Mol. Cell. Biol. 23 (2003) 1269-1277
4. Ink4c and Pten constrain a positive regulatory loop between cell growth and cell cycle control. Mol. Cell. Biol. 26 (2006) 4564-4576
5. Chang H.Y., Nuyten D.S., Sneddon J.B., Hastie T., Tibshirani R., Sorlie T., Dai H., He Y.D., van't Veer L.J., Bartelink H., et al. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc. Natl. Acad. Sci. USA 102 (2005) 3738-3743
6. Chepko G., Slack R., Carbott D., Khan S., Steadman L., and Dickson R.B. Differential alteration of stem and other cell populations in ducts and lobules of TGFalpha and c-Myc transgenic mouse mammary epithelium. Tissue Cell 37 (2005) 393-412
7. Dontu G., Abdallah W.M., Foley J.M., Jackson K.W., Clarke M.F., Kawamura M.J., and Wicha M.S. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17 (2003) 1253-1270
8. Fan C., Oh D.S., Wessels L., Weigelt B., Nuyten D.S., Nobel A.B., van't Veer L.J., and Perou C.M. Concordance among gene-expression-based predictors for breast cancer. N. Engl. J. Med. 355 (2006) 560-569
9. Fantl V., Stamp G., Andrews A., Rosewell I., and Dickson C. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev. 9 (1995) 2364-2372
10. KIP1 mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev. 12 (1998) 2899-2911
11. Herschkowitz J.I., Simin K., Weigman V.J., Mikaelian I., Usary J., Hu Z., Rasmussen K.E., Jones L.P., Assefnia S., Chandrasekharan S., et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol. 8 (2007) R76
12. Hu Z., Fan C., Oh D.S., Marron J.S., He X., Qaqish B.F., Livasy C., Carey L.A., Reynolds E., Dressler L., et al. The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 7 (2006) 96
13. Janzen V., Forkert R., Fleming H.E., Saito Y., Waring M.T., Dombkowski D.M., Cheng T., DePinho R.A., Sharpless N.E., and Scadden D.T. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 443 (2006) 421-426
14. Kouros-Mehr H., Slorach E.M., Sternlicht M.D., and Werb Z. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 127 (2006) 1041-1055
15. Kouros-Mehr H., Bechis S.K., Slorach E.M., Littlepage L.E., Egeblad M., Ewald A.J., Pai S.Y., Ho I.C., and Werb Z. GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell 13 (2008) 141-152
16. Krishnamurthy J., Torrice C., Ramsey M.R., Kovalev G.I., Al-Regaiey K., Su L., and Sharpless N.E. Ink4a/Arf expression is a biomarker of aging. J. Clin. Invest. 114 (2004) 1299-1307
17. Krishnamurthy J., Ramsey M.R., Ligon K.L., Torrice C., Koh A., Bonner-Weir S., and Sharpless N.E. p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 443 (2006) 453-457
18. INK4c cell cycle inhibitors in proliferation and tumorigenesis. EMBO J. 19 (2000) 3496-3506
19. Mehra R., Varambally S., Ding L., Shen R., Sabel M.S., Ghosh D., Chinnaiyan A.M., and Kleer C.G. Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis. Cancer Res. 65 (2005) 11259-11264
20. INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature 443 (2006) 448-452
21. Ormandy C.J., Musgrove E.A., Hui R., Daly R.J., and Sutherland R.L. Cyclin D1, EMS1 and 11q13 amplification in breast cancer. Breast Cancer Res. Treat. 78 (2003) 323-335
22. Pai S.Y., Truitt M.L., Ting C.N., Leiden J.M., Glimcher L.H., and Ho I.C. Critical roles for transcription factor GATA-3 in thymocyte development. Immunity 19 (2003) 863-875
23. Ink4c collaborates with Men1 to constrain lung stem cell expansion and suppress non-small-cell lung cancers. Cancer Res. 67 (2007) 3162-3170
24. Perou C.M., Sorlie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Rees C.A., Pollack J.R., Ross D.T., Johnsen H., Akslen L.A., et al. Molecular portraits of human breast tumours. Nature 406 (2000) 747-752
25. Ponnaiya B., Cornforth M.N., and Ullrich R.L. Radiation-induced chromosomal instability in BALB/c and C57BL/6 mice: the difference is as clear as black and white. Radiat. Res. 147 (1997) 121-125
26. Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues. Cancer Res. 67 (2007) 4732-4741
27. Schmitz N.M., Leibundgut K., and Hirt A. MCM4 shares homology to a replication/DNA-binding domain in CTF and is contacted by pRb. Biochem. Biophys. Res. Commun. 317 (2004) 779-786
28. Shackleton M., Vaillant F., Simpson K.J., Stingl J., Smyth G.K., Asselin-Labat M.L., Wu L., Lindeman G.J., and Visvader J.E. Generation of a functional mammary gland from a single stem cell. Nature 439 (2006) 84-88
29. Sherr C.J. Cancer cell cycle. Science 274 (1996) 1672-1677
30. Sicinski P., Donaher J.L., Parker S.B., Li T., Fazeli A., Gardner H., Haslam S.Z., Bronson R.T., Elledge S.J., and Weinberg R.A. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82 (1995) 621-630
31. Sleeman K.E., Kendrick H., Ashworth A., Isacke C.M., and Smalley M.J. CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells. Breast Cancer Res. 8 (2006) R7
32. Sleeman K.E., Kendrick H., Robertson D., Isacke C.M., Ashworth A., and Smalley M.J. Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland. J. Cell Biol. 176 (2007) 19-26
33. Smith G.H. Label-retaining epithelial cells in mouse mammary gland divide asymmetrically and retain their template DNA strands. Development 132 (2005) 681-687
34. Smith G.H., and Medina D. A morphologically distinct candidate for an epithelial stem cell in mouse mammary gland. J. Cell Sci. 90 (1988) 173-183
35. Sorlie T., Tibshirani R., Parker J., Hastie T., Marron J.S., Nobel A., Deng S., Johnsen H., Pesich R., Geisler S., et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. USA 100 (2003) 8418-8423
36. Stingl J., Eaves C.J., Zandieh I., and Emerman J.T. Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue. Breast Cancer Res. Treat. 67 (2001) 93-109
37. Stingl J., Eirew P., Ricketson I., Shackleton M., Vaillant F., Choi D., Li H.I., and Eaves C.J. Purification and unique properties of mammary epithelial stem cells. Nature 439 (2006) 993-997
38. Ullrich R.L., Bowles N.D., Satterfield L.C., and Davis C.M. Strain-dependent susceptibility to radiation-induced mammary cancer is a result of differences in epithelial cell sensitivity to transformation. Radiat. Res. 146 (1996) 353-355
39. Uziel T., Zindy F., Xie S., Lee Y., Forget A., Magdaleno S., Rehg J.E., Calabrese C., Solecki D., Eberhart C.G., et al. The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation. Genes Dev. 19 (2005) 2656-2667
40. van de Rijn M., Perou C.M., Tibshirani R., Haas P., Kallioniemi O., Kononen J., Torhorst J., Sauter G., Zuber M., Kochli O.R., et al. Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am. J. Pathol. 161 (2002) 1991-1996
41. van de Vijver M.J., He Y.D., van't Veer L.J., Dai H., Hart A.A., Voskuil D.W., Schreiber G.J., Peterse J.L., Roberts C., Marton M.J., et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347 (2002) 1999-2009
42. Wang T.C., Cardiff R.D., Zukerberg L., Lees E., Arnold A., and Schmidt E.V. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369 (1994) 669-671
43. Welm B.E., Tepera S.B., Venezia T., Graubert T.A., Rosen J.M., and Goodell M.A. Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev. Biol. 245 (2002) 42-56
44. Yu Q., Geng Y., and Sicinski P. Specific protection against breast cancers by cyclin D1 ablation. Nature 411 (2001) 1017-1021
45. Yu Q., Sicinska E., Geng Y., Ahnstrom M., Zagozdzon A., Kong Y., Gardner H., Kiyokawa H., Harris L.N., Stal O., et al. Requirement for CDK4 kinase function in breast cancer. Cancer Cell 9 (2006) 23-32
46. Zarkowska T., U S., Harlow E., and Mittnacht S. Monoclonal antibodies specific for underphosphorylated retinoblastoma protein identify a cell cycle regulated phosphorylation site targeted by CDKs. Oncogene 14 (1997) 249-254
47. ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1. Proc. Natl. Acad. Sci. USA 95 (1998) 2429-2434
48. INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene 15 (1997) 203-211